Zydus Lifesciences share price gained more than 3 percent in the early trade on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback